Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The Company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.

Hatfield, PA, USA

Code Biotherapeutics

Alix Ventures

BIOS Community

Leverage our network to build your career.

#### Welcome!

Thank you for joining Bios Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Bios network as they come up.

You can always update this information later.

Welcome to the Bios talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Bios company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join TechBio Companies Driving Patient Impact